{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:12:45Z","timestamp":1778649165704,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dexamethasone (DXM) is used as an empirical adjuvant in IVF\/ICSI, but evidence for its benefit remains inconsistent, and the clinical importance of initiation timing during controlled ovarian stimulation (COS) is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 644 COS cycles at a tertiary reproductive center. Cycles were classified as no DXM (n = 185), early-follicular DXM (stimulation days 0-4; n = 296), mid-follicular DXM (days 5-7; n = 69), or late\/trigger-day DXM (day \u22658 or hCG day; n = 94). DXM was prescribed at the treating physician\u2019s discretion, mainly for cycles considered at increased risk of premature progesterone elevation, and was administered as oral dexamethasone acetate once daily at 0.75-1.125 mg\/day, predominantly 0.75 mg\/day. Ovarian response, embryo development, and total usable embryos were analyzed in the full COS cohort. Pregnancy outcomes were analyzed among post-transfer cycles, and neonatal outcomes among deliveries. Multivariable logistic regression, propensity score-based inverse probability of treatment weighting, and mediation analysis were used to assess associations and address confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mid- and late\/trigger DXM cycles generated more transferable and frozen embryos and more total usable embryos than cycles without DXM. In the post-transfer cohort, early- and mid-follicular DXM were associated with higher live-birth rates than no DXM, whereas late\/trigger DXM showed no clear live-birth advantage. Adjusted and propensity score-weighted models produced consistent estimates. Mediation analysis did not show significant evidence that total usable embryos mediated the association between early DXM and live birth. Neonatal outcomes, including gestational age, birthweight, preterm birth, low birthweight, and congenital malformations, did not differ significantly by DXM timing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this retrospective cohort, DXM timing was associated with distinct reproductive outcomes. Early- and mid-follicular DXM were associated with higher live birth after transfer, whereas late\/trigger DXM did not show clear clinical benefit. These findings should be interpreted cautiously given the clinically selected nature of DXM use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1764227","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:44:37Z","timestamp":1778647477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing of dexamethasone initiation during controlled ovarian stimulation and live birth after IVF\/ICSI: a retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Ling","family":"Zhang","sequence":"first","affiliation":[{"name":"Centre for Reproductive Medicine, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Tang","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Qin","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Tang","sequence":"additional","affiliation":[{"name":"Centre for Reproductive Medicine, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.animal.2023.100866","article-title":"Environment of the ovulatory follicle: modifications and use of biotechnologies to enhance oocyte competence and increase fertility in cattle","volume":"17","author":"Costa","year":"2023","journal-title":"Animal"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1324429","article-title":"Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging","volume":"14","author":"Orisaka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-025-01606-5","article-title":"Immune imbalance in the pre-ovulatory follicular microenvironment of overweight and obese women during IVF","volume":"18","author":"Liu","year":"2025","journal-title":"J Ovarian Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470283","article-title":"Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14228163","article-title":"Implantation failure: Where to look up","volume":"14","author":"Makrigiannakis","year":"2025","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/reprodmed6020014","article-title":"Chronic endometritis: A silent contributor to infertility and reproductive failure\u2014a comprehensive review","volume":"6","author":"Lucan","year":"2025","journal-title":"Reprod Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/rep-22-0150","article-title":"Immunomodulation for unexplained recurrent implantation failure: where are we now","volume":"165","author":"Genest","year":"2023","journal-title":"Reproduction"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1627514","article-title":"Comparing the circulating immune profile of women with and without recurrent implantation failure: a systematic review and meta-analysis","volume":"16","author":"Bhatt","year":"2025","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoad023","article-title":"ESHRE good practice recommendations on recurrent implantation failure","volume":"2023","author":"Cimadomo","year":"2023","journal-title":"Hum Reprod Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.819406","article-title":"Glucocorticoids improve the pregnancy rate and outcome in women with unexplained positive autoantibodies: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4342367","article-title":"Is glucocorticoid use associated with a higher clinical pregnancy rate of in vitro fertilization and embryo transfer? A meta-analysis","volume":"9","author":"Lv","year":"2023","journal-title":"Heliyon"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2023.2227310","article-title":"Glucocorticoid supplementation during ovulation induction for assisted reproductive technology: a systematic review and meta-analysis","volume":"36","author":"Lin","year":"2023","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5653\/cerm.2021.04819","article-title":"Glucocorticoid therapy in assisted reproduction","volume":"48","author":"Kim","year":"2021","journal-title":"Clin Exp Reprod Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005996","article-title":"Peri-implantation glucocorticoid administration for assisted reproductive technology cycles","volume":"6","author":"Boomsma","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.61622\/rbgo\/2024rbgo70","article-title":"Immunosuppressants in women with repeated implantation failure in assisted reproductive techniques: a systematic review and meta-analysis","volume":"46","author":"Santos","year":"2024","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41420-025-02753-w","article-title":"Efficacy of glucocorticoids treatment in recurrent embryo implantation failure","volume":"11","author":"Cai","year":"2025","journal-title":"Cell Death Discov"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5302","article-title":"Prednisone vs placebo and live birth in patients with recurrent implantation failure undergoing in vitro fertilization: a randomized clinical trial","volume":"329","author":"Sun","year":"2023","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew186","article-title":"Corticosteroid therapy in assisted reproduction\u2013immune suppression is a faulty premise","volume":"31","author":"Robertson","year":"2016","journal-title":"Hum Reprod"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.982230","article-title":"Ovulation induction techniques in women with polycystic ovary syndrome","volume":"9","author":"Vyrides","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3390\/biomedicines11061567","article-title":"Immunological and metabolic causes of infertility in polycystic ovary syndrome","volume":"11","author":"Kici\u0144ska","year":"2023","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1038\/s41467-024-49749-1","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s43043-023-00158-2","article-title":"Inflammatory perspectives of polycystic ovary syndrome: role of specific mediators and markers","volume":"28","author":"Dey","year":"2023","journal-title":"Middle East Fertility Soc J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2018.05.009","article-title":"The role of immunotherapy in in vitro fertilization: a guideline","volume":"110","author":"Electronic address Aao","year":"2018","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI(dagger)","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum Reprod Open"},{"key":"B26","volume-title":"ESHRE good practice recommendations for add-ons in reproductive medicine","author":"Vlaisavljevic","year":"2022"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000905324.80042.30","article-title":"Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis","volume":"176","author":"Ninan","year":"2022","journal-title":"JAMA Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1530\/joe-22-0306","article-title":"Antenatal steroids: benefits, risks, and new insights","volume":"258","author":"Fee","year":"2023","journal-title":"J Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004575","article-title":"Long-term outcomes of antenatal corticosteroids for preterm birth: an overview of systematic reviews","volume":"5","author":"Sultana","year":"2025","journal-title":"PloS Global Public Health"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075835","article-title":"Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study","volume":"382","author":"Yao","year":"2023","journal-title":"BMJ"},{"key":"B31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1037\/a0020761","article-title":"A general approach to causal mediation analysis","volume":"15","author":"Imai","year":"2010","journal-title":"Psychol Methods"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1536867x1101100407","article-title":"Mediation: R package for causal mediation analysis","volume":"59","author":"Tingley","year":"2014","journal-title":"J Stat Software"},{"key":"B34","volume-title":"Causal inference","author":"Hern\u00e1n","year":"2010"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000005950","article-title":"Antenatal corticosteroids and child neurodevelopment: a systematic review and meta-analysis","volume":"146","author":"Liauw","year":"2025","journal-title":"Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004618","article-title":"Twenty-year outcomes after repeat doses of antenatal corticosteroids prior to 32 weeks' gestation: follow-up of a randomised clinical trial","volume":"22","author":"May","year":"2025","journal-title":"PloS Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1764227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:44:57Z","timestamp":1778647497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1764227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":36,"alternative-id":["10.3389\/fendo.2026.1764227"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1764227","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1764227"}}